Delivery Order SPE2DR25D1106-SPE2DR26FHZ8B
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,588.88 to AmerisourceBergen Drug Corp for the supply of Humira Pen 40 mg/0.8 mls, a pharmaceutical product used to treat autoimmune conditions. This competitive award, issued on October 30, 2025, with an ultimate completion date of October 31, 2025, represents a firm fixed-price delivery order with no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $1,591.94 to AmerisourceBergen Drug Corp for the supply of HUMIRA (CF) Pen 80 mg/0.8 mls, a pharmaceutical product used in the treatment of autoimmune conditions. This firm fixed-price contract, issued on November 10, 2025, with an ultimate completion date of November 12, 2025, was competitively awarded with no set-aside designation. The product will be delivered to Conshohocken, Pennsylvania, the location of AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,194.43 to AmerisourceBergen Drug Corp for the supply of HUMIRA (CF) Pen 40 mg/0.4 mls, a pharmaceutical product used in the treatment of inflammatory conditions. This non-competitive delivery order was issued on October 14, 2025, with an ultimate completion date of October 15, 2025, and is priced on a firm fixed-price basis. The products will be delivered to AmerisourceBergen's location in Conshohocken, Pennsylvania, the...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,787.90 to AmerisourceBergen Drug Corp for HUMIRA Pen 40 mg/0.8 mls, a pharmaceutical product used in the treatment of autoimmune conditions. This non-competitive, firm fixed-price delivery order was issued on November 17, 2025, with an ultimate completion date of November 18, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a single transaction under...
- The Defense Logistics Agency has awarded a delivery order valued at $1,510.60 to AmerisourceBergen Drug Corp for the supply of HUMIRA (CF) Pen 40 mg/0.4 mls, a brand-name pharmaceutical product used in the treatment of autoimmune conditions. This competitively awarded, firm fixed-price delivery order was executed on August 27, 2025, with an ultimate completion date of August 28, 2025. The contract will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,662.84 to AmerisourceBergen Drug Corp for HUMIRA (CF) Pen 40 mg/0.4 mls, a pharmaceutical product for treating inflammatory conditions. This competitively awarded, firm fixed-price delivery order was issued on November 4, 2025, with an ultimate completion date of November 5, 2025. The contract involves no set-aside designation and is being performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $11,549.73 to AmerisourceBergen Drug Corp for the supply of HUMIRA (CF) Pen 40 mg/0.4 mL, a brand-name pharmaceutical product used in the treatment of autoimmune conditions. This competitively awarded, firm fixed-price delivery order was issued on November 6, 2025, with an ultimate completion date of November 7, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The contract carries no...
- The Defense Logistics Agency awarded a delivery order valued at $1,768.16 to AmerisourceBergen Drug Corp for HUMIRA (CF) Pen 40 mg/0.4 mls, a pharmaceutical product used for treating autoimmune conditions. The contract was awarded on November 5, 2025, with an ultimate completion date of November 6, 2025, and is structured as a firm fixed price delivery order with no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,207.72 to AmerisourceBergen Drug Corp for HUMIRA (CF) Pen 40 mg/0.4 mls on November 3, 2025, with an ultimate completion date of November 4, 2025. This is a firm fixed price, competitively awarded delivery order with no set-aside designation, issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.999 billion through December 2026. The place of...
- The Defense Logistics Agency awarded a competitive delivery order valued at $1,591.96 to AmerisourceBergen Drug Corp for the supply of HUMIRA (CF) Pen 40 mg/0.4 mls, an injectable pharmaceutical product used to treat autoimmune conditions. The award was made on November 13, 2025, with an ultimate completion date of November 14, 2025, utilizing firm fixed pricing with no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- SPE2DR25D1106Indefinite Delivery Contract
- SPE2DR25D1106-SPE2DR26FHZ8BDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,598.02 to AmerisourceBergen Drug Corp for the supply of HUMIRA (CF) Pen 40 mg/0.4 mls, a pharmaceutical product used in the treatment of autoimmune conditions. This non-competitive, firm fixed-price delivery order was awarded on November 17, 2025, with an ultimate completion date of November 18, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the DLA Medical Supply Chain. The company's substantial IDC enables it to supply a broad range of pharmaceutical products and medical supplies—including specialty medications, brand-name and generic drugs, vaccines, and medical devices—to support defense health operations worldwide. As a prime contractor under this vehicle, AmerisourceBergen serves multiple federal healthcare customers including the Defense Health Agency and U.S. Coast Guard, demonstrating its capability to fulfill complex federal pharmaceutical supply requirements through competitive procurement processes.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 11/17/25 |